Global Women’s Health Market

$3,500.00$7,500.00

  • Type: Therapeutics Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 361

  • Format: PPT, PDF

Global Women’s Health Market: Segmented by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel) and by Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and Latin America) – Growth, Trend Analysis, and Forecasts (2019 – 2028)

Clear

Report Overview

The global women’s health market size stood at around USD 32 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Women’s health includes all of the therapeutics, drugs, and surgical offerings precautionary measures for the various disorders associated with the women population. These disorders vary from nutrition, oncology, reproductive, menopause, urological as well as other healthcare applications. Women’s health is focused on providing better management of diseases and improving the overall health of women population.

Market Drivers

Increasing prevalence of preventing women related health disorders by the population and authorities is expected to promote the market value. Rise in the levels of research & development initiatives undertaken by various manufacturers in providing better healthcare services for women is expected to positively affect the growth of the market as well. Lack of qualitative healthcare services for women from the under-developed regions of the world is expected to provide better areas for growth of the market value. Changes in the lifestyle of individuals coupled with bad nutritional intake are factors driving the growth of the market.

Major Women’s Health Disease Indication

The women’s health market has been segmented into postmenopausal osteoporosis, menopause, endometriosis, contraceptives, hormonal infertility, and polycystic ovary syndrome (PCOS). The postmenopausal osteoporosis segment accounted for one of the largest shares of the market in 2019, due to the growing population of women aged 40 and above and the launch of various drugs to cure menopausal osteoporosis and improve health.

The hormonal infertility segment is expected to grow rapidly owing to high fertility-related conditions in developed countries. Moreover, the easy availability of several medicines to cure hormonal imbalance and market players’ investments in new product development would drive the segment growth over the forecast period. Hormonal imbalance such as the imbalance of prolactin, estrogen, and thyroid is increasing in women due to factors such as stress, further driving the demand for medication to improve health.

1. Global Women’s Health Market Overview………………………………………….
A. Market Size
2. Market Growth Drivers……………………………………………………..…………
A. Growing Incidence of Chronic Health Conditions Among Women
B. Growing Focus on Product R&D
3. Major Women’s Health Disease Indication…………………………………………
A. Postmenopausal Osteoporosis
B. Hormonal Infertility
C. Endometriosis
D. Contraceptives
E. Menopause
F. PCOS
G. Others
4. Women’s Health Market Segmentation……………..……………………………….
A. By Drug
I. Prolia
II. Xgeva
III. Evista
IV. Mirena
V. Zometa
VI. Reclast
VII. Nuvaring
VIII. Primarin
IX. Actonel
X. Ortho-Tri-Cy Lo 28
XI. Forteo
XII. Minastrin 24FE
B. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. Latin America Market Analysis
C. By Application
I. Contraceptives
II. Menopause
III. Hormonal Infertility
IV. Postmenopausal Osteoporosis
V. Endometriosis
VI. PCOS
VII. Others
5. Women’s Health Major Drugs Market Share………………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape………………………………………………………….……..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Allergan Company overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
C. Merck & Co. Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………..……
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. Key Industry Developments in market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug:

Based on drug, the market is segmented into Evista, Xgeva, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 FE, Nuvaring, Forteo, Premarin, Actonel, and Ortho-Tri-Cy Lo 28. Prolia is the fastest-growing segment of the market. Also, Prolia accounted for the larger share of the market in 2019. The increasing demand for Prolia due to the high prevalence of postmenopausal osteoporosis among women is the major factor responsible for the growth of this market segment.

By Region:

By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America dominated the global women’s health market in 2019. This is attributed to the existence of key market players, reimbursement policies, supportive government regulations, approval and commercialization of products, and growing awareness about the importance of maintaining good health. The market is also driven by the increasing number of FDA approvals of menopausal drugs, high healthcare expenditure, and a rise in preference for biologics among women. In October 2018, the U.S. FDA approved TherapeuticsMD’s Bijuva, a soft gel capsule containing estradiol and progesterone. The drug is approved as a single pill hormone therapy for menopausal hot flashes.

Asia Pacific is projected to grow at the fastest rate over the forecast period. This is attributed to the rising awareness about women’s wellbeing and health, growing prevalence of osteoarthritis, infertility, and other disorders due to stress, and various government programs for increasing health awareness.

By Application:

By application, contraceptives accounted for the largest market share of the women’s health market in 2019

Contraceptives dominated the market with a share of over 43.0% in 2019 in terms of revenue. Use of female contraception is beneficial in the prevention of health issues associated with pregnancy, particularly for pubescent girls, as well as in pregnancy planning to reduce the chances of infant mortality, which is higher in childbirths separated by a lesser number of years. Besides, it provides various other prospective benefits comprising prolonged prospects for education and women empowerment, along with maintaining a healthy population and economic growth of nations.

Postmenopausal osteoporosis held the second-largest market share in 2019, owing to the concern associated with decreasing bone density and an increase in chances of having fractures followed by Hormonal infertility, Menopause, Endometriosis, PCOS and others.

Top 5 Major Players

Some of the key players operating in the market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V. Collaborations for product development, expansion of product portfolios, and regional expansion in emerging markets are the key strategic undertakings of these companies to increase their market share.

 

 

 

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements